• Policy
• Reducing criminal liability for essential healthcare
• by Lee, Jeong-Hwan Oct 6, 2023 05:36am

• Company
• SCD accelerates EU approval of Eylea biosimilar
• by Nho, Byung Chul Oct 5, 2023 05:27am

• Company
• New drugs only account for 8.5% of all drug spending in KOR
• by Eo, Yun-Ho Oct 5, 2023 05:27am

• Company
• GSK Korea appoints Maurizio Borgatta as new General Manager
• by Oct 5, 2023 05:27am

• Company
• The reimbursement process for Cosentyx and Taltz
• by Eo, Yun-Ho Oct 5, 2023 05:27am

• Policy
• Health plans expected to be implemented after NA audit
• by Lee, Jeong-Hwan Oct 5, 2023 05:27am

• Policy
• Medical expenses exceed ₩1 trillion
• by Lee, Tak-Sun Oct 4, 2023 05:35am

• Company
• Price cuts for 35 generics suspended…only 0.5% of all
• by Chon, Seung-Hyun Oct 4, 2023 05:35am

• Company
• New urothelial cancer drug Padcev attempts reimb in KOR
• by Eo, Yun-Ho Oct 4, 2023 05:35am

• Policy
• New pharmaceutical data protection system begins
• by Lee, Jeong-Hwan Oct 4, 2023 05:35am